Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1134983

registered interest
date	01/07/2019
answering body	Department for Education
answering dept id	60
answering dept short name	Education
answering dept sort name	Education
hansard heading	Speech and Language Therapy: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Education, with reference the June 2019 report of the Children’s Commissioner, We need to talk: access to speech and language therapy, if he will meet with the Local Government Association to discuss the implications for his Department's policies of the findings of that report.
tabling member constituency	Swansea West
tabling member printed	Geraint Davies
uin	269599
answer	answer is ministerial correction date of answer 05/07/2019 answer text <p>We are committed to ensuring more effective support for children and young people with speech, language and communication needs (SLCN). Ministers from the Department for Education (DfE) regularly meet with local government to discuss issues relating to special educational needs and disabilities (SEND), including SLCN.</p><p> </p><p>On 20 May 2019, we held the first SEND ministerial roundtable meeting between ministers from the DfE, Department for Health and Social Care (DHSC) and key SEND stakeholders to help inform future SEND policy. We will also be using these meetings to help inform the SEND System Leadership Board which aims to improve joint working and strategic commissioning for all children and young people with SEND, including those with SLCN.</p><p> </p><p>On 20 June 2019, the government issued a letter to I CAN and The Royal College of Speech and Language Therapists. That letter responded to the Bercow One Year Anniversary update report, and was co-signed by ministers from the DfE, DHSC and the Ministry of Justice. The letter reaffirms our commitment to supporting children and young people with SLCN, and sets out the key action the government is taking to address SLCN. A copy of the letter will be placed in the Libraries of both Houses.</p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 05/07/2019 09:36:56 answering member 4113 label Biography information for Nadhim Zahawi
tabling member	155 label Biography information for Geraint Davies

1135166

registered interest
date	27/06/2019
answering body	Treasury
answering dept id	14
answering dept short name	Treasury
answering dept sort name	Treasury
hansard heading	Share Fishermen: Taxation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Chancellor of the Exchequer, whether people participating in the Share Fisherman Scheme will be able to continue to participate in the scheme for the length of their working lives.
tabling member constituency	Oxford East
tabling member printed	Anneliese Dodds
uin	270381
answer	answer is ministerial correction date of answer 05/07/2019 answer text <p>The current voluntary payment scheme for share fishermen was introduced to help customers with an uncertain earning pattern to save towards their income tax liability, which is accounted for and paid via the annual self-assessment (SA) process. The scheme is supported by Barclays, operating special bank accounts, from which HMRC can periodically withdraw funds.</p><p>These arrangements no longer meet banking regulations. There has also been very low take-up of the voluntary payment scheme, so HMRC are working with Barclays to review what services can be offered to share fishermen in future, taking into account developments in the income tax self-assessment process and wider tax administration as well as the payment options available to other taxpayers.</p> answering member constituency Hereford and South Herefordshire answering member printed Jesse Norman question first answered 05/07/2019 09:47:58 answering member 3991 label Biography information for Jesse Norman
tabling member	4657 label Biography information for Anneliese Dodds

1135167

registered interest
date	27/06/2019
answering body	Department for Work and Pensions
answering dept id	29
answering dept short name	Work and Pensions
answering dept sort name	Work and Pensions
hansard heading	Universal Credit
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Work and Pensions, what assessment she has made of the effect of the (a) wait for payment and (b) monthly payment of universal credit on the number of weeks of benefit paid annually to claimants compared with the number they were paid under their legacy benefits.
tabling member constituency	Derby North
tabling member printed	Chris Williamson
uin	270345
answer	answer is ministerial correction date of answer 05/07/2019 answer text <p>There is no need to wait for a Universal Credit payment, as 100 per cent advances are available from day one of a claim. Advance payments are simply an advance of entitlement, meaning that by month 12 of a claim, a claimant would normally have received exactly the same Universal Credit regardless of whether they had an advance or not.</p><p> </p><p>Furthermore, frequency of payment should not affect the total amount of Universal Credit paid over the course of a year. Whilst legacy benefits were paid in two-weekly arrears, Universal Credit is paid in monthly arrears to help reduce welfare dependency by mirroring the world of work, where currently around 70 per cent of tax credit claimants are paid monthly or four weekly.</p><p> </p><p>We know that claimants are currently not getting all the entitlements for which they are eligible on legacy benefits. Requiring claimants to make a new Universal Credit claim will ensure that people will not miss out on any entitlements. This will result in an additional £2.4 billion going to 700,000 families who currently do not take up their full benefit entitlement.</p> answering member constituency Reading West answering member printed Alok Sharma question first answered 05/07/2019 13:04:00 answering member 4014 label Biography information for Sir Alok Sharma
tabling member	3976 label Biography information for Chris Williamson

1135173

registered interest
date	27/06/2019
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Electronic Funds Transfer: Fraud
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, what recent discussions his Department has had with banks on the retrospective application of the Authorised Push Payment Scams voluntary code.
tabling member constituency	Ogmore
tabling member printed	Chris Elmore
uin	270386
answer	answer is ministerial correction date of answer 03/07/2019 answer text <p>A new industry voluntary Contingent Reimbursement Model Code for Authorised Push Payment Scam was introduced on 28 May 2019.</p><p><br>Customers of those payment service providers that are signatories are protected under the Code from this date. At the outset of the design of the Code, the steering group stated that it will only apply to APP scams occurring after its implementation.</p> answering member constituency Wyre and Preston North answering member printed Mr Ben Wallace question first answered 03/07/2019 15:43:30 answering member 1539 label Biography information for Mr Ben Wallace
tabling member	4572 label Biography information for Chris Elmore

1135174

registered interest
date	27/06/2019
answering body	Foreign and Commonwealth Office
answering dept id	16
answering dept short name	Foreign and Commonwealth Office
answering dept sort name	Foreign and Commonwealth Office
hansard heading	USA: Detention Centres
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Foreign and Commonwealth Affairs, if he will make representations to his US counterpart on (a) the human rights of (i) children and (ii) others held without provision of (A) soap, (B) toothbrushes and (C) beds in the US-run border detention centres on the US-Mexican border and (b) closing those centres; and if he will make a statement.
tabling member constituency	Brighton, Pavilion
tabling member printed	Caroline Lucas
uin	270324
answer	answer is ministerial correction date of answer 03/07/2019 answer text <p>We are aware of recent concerning reports describing conditions for children in US detention facilities. The US Congress passed a Bill on 27 June providing emergency funding, including humanitarian support, in part to help address those conditions. We will continue to monitor the situation, though immigration policy in the US is of course a matter for the US Government, just as immigration policy in the UK is decided by the British Government.</p> answering member constituency Rutland and Melton answering member printed Sir Alan Duncan grouped question UIN 270327 question first answered 03/07/2019 15:24:06 answering member 343 label Biography information for Sir Alan Duncan
tabling member	3930 label Biography information for Caroline Lucas

1135179

registered interest
date	27/06/2019
answering body	Department for Transport
answering dept id	27
answering dept short name	Transport
answering dept sort name	Transport
hansard heading	Railways: Repairs and Maintenance
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Transport, what assessment he has made of the effectiveness of Network Rail's emergency maintenance on the rail network in the past five years.
tabling member constituency	Dulwich and West Norwood
tabling member printed	Helen Hayes
uin	270388
answer	answer is ministerial correction date of answer 03/07/2019 answer text <p>It is a matter for the independent regulator, the Office of Rail and Road (ORR), to assess the effectiveness of NR’s maintenance activity and its impact on the performance of the rail network. ORR reports every six months on its assessment of how Network Rail is performing in the “Network Rail Monitor”, which is available on the ORR’s website at ORR.gov.uk.</p> answering member constituency Harrogate and Knaresborough answering member printed Andrew Jones question first answered 03/07/2019 09:06:25 answering member 3996 label Biography information for Andrew Jones
tabling member	4510 label Biography information for Helen Hayes

1135182

registered interest
date	27/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Genomics: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, which diagnostic tests will whole genome sequencing replace, particularly for blood cancers.
tabling member constituency	Sheffield South East
tabling member printed	Mr Clive Betts
uin	270281
answer	answer is ministerial correction date of answer 05/07/2019 answer text <p>During 2019, the National Health Service will begin to offer whole genome sequencing (WGS) as part of clinical care for:</p><p>- Seriously ill children likely to have a rare genetic disorder;</p><p>- People with one of 21 rare conditions where current evidence supports early adoption of WGS as a diagnostic test; and</p><p>- People with specific types of cancer for which there is likely to be the greatest patient benefit from using WGS – children with cancer, sarcoma and acute myeloid leukaemia.</p><p> </p><p>WGS will only replace existing diagnostic tests once the testing is demonstrated to be clinically safe to replace existing diagnostic testing. Initially, existing diagnostic testing will continue to be performed alongside WGS testing where clinically appropriate. This will continue until WGS is able to fully support clinical decision making within clinically appropriate timescales.</p><p>Current testing for blood cancers includes a number of diagnostic tests, the current expectation is that WGS will not be used to replace tests that require very fast turnaround times (under 24 hours) or high sensitivity.</p><p>WGS and non-WGS testing that will be available as part of clinical care is outlined in the National Genomic Test Directory at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/publication/national-genomic-test-directories/" target="_blank">https://www.england.nhs.uk/publication/national-genomic-test-directories/</a></p><p> </p><p>The UK Genetic Testing Network (UKGTN) published the NHS Directory of Genetic Disorders/Genes for Diagnostic Testing, which evaluated and recommended genetic tests for rare and inherited disorders for the National Health Service across the UK. However, there was not an equivalent for cancer genomic testing. The National Genomic Test Directory specifies which genomic tests are commissioned by the NHS in England, the technology by which they are available, and the patients who will be eligible to access to a test.</p><p>The National Genomic Test Directory will be updated on an annual basis and NHS England will implement a clear and transparent process, supported by a Clinical and Scientific Expert Panel, to determine which tests are available within the NHS. This will include reviewing any tests that may be retired or replaced by more modern technology, such as WGS. As the price of WGS falls and the clinical evidence improves, we envisage that it will be extended to more conditions and therefore more patients.</p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 270282 270283 question first answered 05/07/2019 09:24:02 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	394 label Biography information for Mr Clive Betts

1135183

registered interest
date	27/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Genetics: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether the National Genomic Test Directory directly replaces the NHS Directory of Genetic Disorders/Genes for Diagnostic Testing.
tabling member constituency	Sheffield South East
tabling member printed	Mr Clive Betts
uin	270282
answer	answer is ministerial correction date of answer 05/07/2019 answer text <p>During 2019, the National Health Service will begin to offer whole genome sequencing (WGS) as part of clinical care for:</p><p>- Seriously ill children likely to have a rare genetic disorder;</p><p>- People with one of 21 rare conditions where current evidence supports early adoption of WGS as a diagnostic test; and</p><p>- People with specific types of cancer for which there is likely to be the greatest patient benefit from using WGS – children with cancer, sarcoma and acute myeloid leukaemia.</p><p> </p><p>WGS will only replace existing diagnostic tests once the testing is demonstrated to be clinically safe to replace existing diagnostic testing. Initially, existing diagnostic testing will continue to be performed alongside WGS testing where clinically appropriate. This will continue until WGS is able to fully support clinical decision making within clinically appropriate timescales.</p><p>Current testing for blood cancers includes a number of diagnostic tests, the current expectation is that WGS will not be used to replace tests that require very fast turnaround times (under 24 hours) or high sensitivity.</p><p>WGS and non-WGS testing that will be available as part of clinical care is outlined in the National Genomic Test Directory at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/publication/national-genomic-test-directories/" target="_blank">https://www.england.nhs.uk/publication/national-genomic-test-directories/</a></p><p> </p><p>The UK Genetic Testing Network (UKGTN) published the NHS Directory of Genetic Disorders/Genes for Diagnostic Testing, which evaluated and recommended genetic tests for rare and inherited disorders for the National Health Service across the UK. However, there was not an equivalent for cancer genomic testing. The National Genomic Test Directory specifies which genomic tests are commissioned by the NHS in England, the technology by which they are available, and the patients who will be eligible to access to a test.</p><p>The National Genomic Test Directory will be updated on an annual basis and NHS England will implement a clear and transparent process, supported by a Clinical and Scientific Expert Panel, to determine which tests are available within the NHS. This will include reviewing any tests that may be retired or replaced by more modern technology, such as WGS. As the price of WGS falls and the clinical evidence improves, we envisage that it will be extended to more conditions and therefore more patients.</p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 270281 270283 question first answered 05/07/2019 09:24:02 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	394 label Biography information for Mr Clive Betts

1135184

registered interest
date	27/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Genomics: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how will new tests be added to the National Genomic Test Directory.
tabling member constituency	Sheffield South East
tabling member printed	Mr Clive Betts
uin	270283
answer	answer is ministerial correction date of answer 05/07/2019 answer text <p>During 2019, the National Health Service will begin to offer whole genome sequencing (WGS) as part of clinical care for:</p><p>- Seriously ill children likely to have a rare genetic disorder;</p><p>- People with one of 21 rare conditions where current evidence supports early adoption of WGS as a diagnostic test; and</p><p>- People with specific types of cancer for which there is likely to be the greatest patient benefit from using WGS – children with cancer, sarcoma and acute myeloid leukaemia.</p><p> </p><p>WGS will only replace existing diagnostic tests once the testing is demonstrated to be clinically safe to replace existing diagnostic testing. Initially, existing diagnostic testing will continue to be performed alongside WGS testing where clinically appropriate. This will continue until WGS is able to fully support clinical decision making within clinically appropriate timescales.</p><p>Current testing for blood cancers includes a number of diagnostic tests, the current expectation is that WGS will not be used to replace tests that require very fast turnaround times (under 24 hours) or high sensitivity.</p><p>WGS and non-WGS testing that will be available as part of clinical care is outlined in the National Genomic Test Directory at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/publication/national-genomic-test-directories/" target="_blank">https://www.england.nhs.uk/publication/national-genomic-test-directories/</a></p><p> </p><p>The UK Genetic Testing Network (UKGTN) published the NHS Directory of Genetic Disorders/Genes for Diagnostic Testing, which evaluated and recommended genetic tests for rare and inherited disorders for the National Health Service across the UK. However, there was not an equivalent for cancer genomic testing. The National Genomic Test Directory specifies which genomic tests are commissioned by the NHS in England, the technology by which they are available, and the patients who will be eligible to access to a test.</p><p>The National Genomic Test Directory will be updated on an annual basis and NHS England will implement a clear and transparent process, supported by a Clinical and Scientific Expert Panel, to determine which tests are available within the NHS. This will include reviewing any tests that may be retired or replaced by more modern technology, such as WGS. As the price of WGS falls and the clinical evidence improves, we envisage that it will be extended to more conditions and therefore more patients.</p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 270281 270282 question first answered 05/07/2019 09:24:02 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	394 label Biography information for Mr Clive Betts

1135185

registered interest
date	27/06/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Air Pollution: Health Hazards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what data his Department holds on the safe level of exposure to (a) PM0.1, (b) PM1 and (c) PM2.5.
tabling member constituency	Stroud
tabling member printed	Dr David Drew
uin	270241
answer	answer is ministerial correction date of answer 04/07/2019 answer text <p>It is not possible to determine, based on the currently available evidence, whether there is a safe level of exposure to particulate matter PM0.1, PM1 or PM2.5.</p><p> </p><p>However, the World Health Organization has developed air quality guidelines for air pollutants. These guidelines can be viewed at the following link:</p><p><a href="https://apps.who.int/iris/bitstream/handle/10665/69477/WHO_SDE_PHE_OEH_06.02_eng.pdf;jsessionid=2BA71982F81800529E1DDB3FDC4838D7?sequence=1" target="_blank">https://apps.who.int/iris/bitstream/handle/10665/69477/WHO_SDE_PHE_OEH_06.02_eng.pdf;jsessionid=2BA71982F81800529E1DDB3FDC4838D7?sequence=1</a></p><p> </p><p> </p><p> </p><p> </p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 04/07/2019 14:19:11 answering member 4455 label Biography information for Seema Kennedy
tabling member	252 label Biography information for Dr David Drew